[144] Cellebrite DI Ltd. Warrants SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Cellebrite DI Ltd. (CLBTW) reports a proposed sale of 11,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $169,665.10 and approximately 239,470,062 shares outstanding. The filing shows the shares were originally acquired as restricted stock from the issuer on three dates: 5,826 shares on 08/31/2023, 3,768 shares on 07/18/2023, and 1,406 shares on 07/06/2024, and no sales by the filer in the past three months were reported.

The filer certifies they are not aware of undisclosed material adverse information about the issuer. The notice is procedural under Rule 144 to disclose an intended sale and does not include transaction proceeds, planned sale method beyond the broker, or additional contextual corporate details.

Positive

• Full compliance details provided: broker name, share class, number of shares, aggregate market value, acquisition dates and methods are disclosed
• No sales reported in prior three months, indicating this filing is not part of an active recent selling pattern

Negative

• Limited context: filing contains no information on whether a 10b5-1 trading plan governs the sale or the exact execution method beyond the broker
• Small disclosure relative to outstanding shares: 11,000 shares versus 239,470,062 outstanding offers minimal informational or market impact

Insights

Securities Analyst

TL;DR: Routine insider sale notice: 11,000 shares (~$170k) flagged via broker for sale under Rule 144, non‑recent selling activity reported.

This Form 144 documents a planned sale of 11,000 common shares of CLBTW with an aggregate market value of $169,665.10 using Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired as restricted stock on three dates in 2023 and 2024, totaling the amount to be sold. No sales in the prior three months are reported. From a market-impact perspective, the size of the notice relative to total shares outstanding (239,470,062) is immaterial; the filing is a compliance disclosure rather than a strategic signal.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signer affirms no undisclosed material information.

The filing contains required elements: broker, class, number of shares, aggregate value, acquisition history identifying restricted stock origin, and the seller's representation about material information. It lacks details on whether a 10b5‑1 plan exists or specific sale mechanics. Governance-wise, the statement that the filer is unaware of undisclosed material information is notable but standard for this form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11000	169665.10	239470062	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2023	Restricted Stock	Issuer			5826	08/31/2023	Not Applicable
Common	07/06/2024	Restricted Stock	Issuer			1406	07/06/2024	Not Applicable
Common	07/18/2023	Restricted Stock	Issuer			3768	07/18/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLBTW Form 144 filed mean?

The filing notifies the market that a person intends to sell 11,000 common shares of CLBTW on or about 08/20/2025 via Morgan Stanley Smith Barney LLC and complies with Rule 144 reporting requirements.

How many CLBTW shares and what is the aggregate value in this Form 144?

The notice covers 11,000 common shares with an aggregate market value of $169,665.10.

When and how were the CLBTW shares being sold acquired?

All shares were received as restricted stock from the issuer: 5,826 on 08/31/2023, 3,768 on 07/18/2023, and 1,406 on 07/06/2024.

Does the Form 144 report prior sales by the filer of CLBTW?

No. The filing states Nothing to Report for securities sold during the past three months.

On which exchange and through which broker will the CLBTW shares be sold?

The filing lists NASDAQ as the exchange and Morgan Stanley Smith Barney LLC as the broker.